Sponsors

Panel for interfering substances

Firefly Scientific has launched its OptiChallenge Inhibition Panel for use in evaluating the performance of an assay in the presence of interfering substances.

The sevenmember panel is the very first to provide quantified amounts of commonly recognised inhibitors. The panel members represent elevated levels of inhibitory substances encountered routinely in the normal patient population.

Interfering substances such as heparin, lipids, bilirubin and haemolysed plasma are found commonly in patient samples. At minimal levels, these substances do not interfere with assay results. However, when levels become elevated due to the effect of lifestyle or medications, these substances can hinder the amplification of nucleic acid assays. Studies show that 12.5% of incorrect and delayed test results affect patient health.

The OptiChallenge Inhibition Panel allows laboratories to identify limitations in testing due to the presence of interfering substances and enables appropriate actions to be taken.

www.fireflyscientific.co.uk

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024